The Online Investor
Diagnostics M&A image Diagnostics M&A » By The Online Investor Staff, updated Wed., Sep. 23, 5:36 AM Recent mergers and acquisitions in the Diagnostics M&A category.

Slide #86. DaVita Nine dialysis centers from Fresenius Medical Care

Acquirer: DaVita (NYSE:DVA)
Acquiree: Nine dialysis centers from Fresenius Medical Care
Details: DaVita, the kidney care division of DaVita HealthCare Partners Inc. (NYSE:DVA) and a leading provider of kidney care services, today announced it has acquired nine dialysis centers from Fresenius Medical Care (`FMC'), a leading provider of dialysis services and manufacturer of dialysis products. Five of the clinics are located in Portugal and four clinics are located in Poland.

DaVita is a healthcare provider focused on transforming care delivery to improve quality of life for patients. Co.'s United States dialysis business provides kidney dialysis services for patients suffering from end stage renal disease (ESRD). Co.'s dialysis services include outpatient hemodialysis services, hospital inpatient hemodialysis services, home-based dialysis services, ESRD laboratory services, and management services. Co.'s ancillary services and strategic initiatives businesses include disease management services, physician services, ESRD Seamless Care Organization joint ventures, clinical research programs, vascular access services, as well as international dialysis operations.

DaVita HealthCare Partners SEC Filing Email Alerts Service

Open the DVA Page at The Online Investor »

Company Name: 
DaVita Inc
Number of ETFs Holding DVA: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 

Open the DVA Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Buy (2.75 out of 4)
25th percentile
(ranked lower than approx. 75% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Diagnostics M&A - Slide 86 of 100 Page |

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.